Albany Mora-Resendiz
Mexico City, DIF 07320, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Anti-lipid IgG antibodies are produced via germinal centers in a murine model resembling human lupus.
Journal: Frontiers in immunology
Published: September 23, 2025
In Vivo Response of γδ T Cells and Macrophages to Non-Bilayer Phospholipid Arrangements in a Lupus-like Mouse Model.
Journal: International journal of molecular sciences
Published: July 31, 2025
Effect of B-NIPOx in Experimental Trypanosoma cruzi Infection in Mice.
Journal: International journal of molecular sciences
Published: December 01, 2022
Liposomes Bearing Non-Bilayer Phospholipid Arrangements Induce Specific IgG Anti-Lipid Antibodies by Activating NK1.1+, CD4+ T Cells in Mice.
Journal: Membranes
Published: May 29, 2022
Interleukin 4 deficiency limits the development of a lupus-like disease in mice triggered by phospholipids in a non-bilayer arrangement.
Journal: Scandinavian journal of immunology
Published: August 04, 2020
Lupresan, a new drug that prevents or reverts the formation of nonbilayer phospholipid arrangements that trigger a murine lupus resembling human lupus.
Journal: Biochemical and biophysical research communications
Published: November 26, 2018
Dysregulation of miR-155-5p and miR-200-3p and the Anti-Non-Bilayer Phospholipid Arrangement Antibodies Favor the Development of Lupus in Three Novel Murine Lupus Models.
Journal: Journal of immunology research
Published: May 31, 2017
Corrigendum: Anti-Lipid IgG Antibodies Are Produced via Germinal Centers in a Murine Model Resembling Human Lupus.
Journal: Frontiers in immunology
Published: January 30, 2017
Anti-Lipid IgG Antibodies Are Produced via Germinal Centers in a Murine Model Resembling Human Lupus.
Journal: Frontiers in immunology
Published: May 03, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026